nach oben

Erschienen in:

01.01.2007 | Original Paper

Efficacy of a Group Medication Adherence Intervention Among HIV Positive Women: The SMART/EST Women’s Project

verfasst von: Deborah L. Jones, Shvawn McPherson-Baker, David Lydston, Joanne Camille, Elizabeth Brondolo, Jonathan N. Tobin, Stephen M. Weiss

Erschienen in: AIDS and Behavior | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

This intervention sought to improve overall quality of life and health behavior in women living with human immunodeficiency virus (HIV). We contrasted the effect of a group cognitive behavioral stress management expressive supportive therapy (CBSM+) intervention plus a healthier lifestyles (HL) component with an individual educational/informational format plus HL on HIV-medication adherence. Women, n = 237, predominantly African-American and Latina, living with HIV were recruited from Miami, New York and New Jersey and randomized to group or individual conditions (ten weekly sessions) plus group or individual HL, i.e., four conditions. Women reported relatively high levels of adherence at baseline. Participants in any of the group conditions increased self-reported adherence and emotion-focused coping skills in comparison with individual participation. This study suggests that group interventions may be an important adjunct in increasing medication adherence for HIV positive women.

Bangsberg, D. R., Hecht, F. M., Clague, H., Chalebois, E. D., Ciccarone, D., Chesney, M., et al. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 26(Suppl. 5), 435–442.

Baron, R. M., & Kenny D. A. (1986). The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51, 1173–1182.PubMedCrossRef

Barre-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., & Gruest, J. (1983). Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science, 220, 868–871.PubMedCrossRef

Boden, D., Hurley, A., Zhang, L., Cao, Y., Guo, Y., Jones, E., et al. (1999). HIV-1 drug resistance in newly infected individuals. Journal of the American Medical Association, 282, 1135–1141.PubMedCrossRef

Bogart, L. M., Gray-Bernhardt, M. L., Catz, S. L., Hartmann, B. R., & Otto-Salaj, L. L. (2002). Social and temporal comparisons made by individuals living with HIV disease: Relationships to adherence behavior. Journal of Applied Social Psychology, 32(Suppl. 8), 1551–1576.CrossRef

Carpenter, C. C. J., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katsenstein, D. A., et al. (2000). Antiretroviral therapy in adults updated recommendations of the international AIDS society—USA panel. Journal of the American Medical Association, 283, 381–390.PubMedCrossRef

Carver, C., Sheier, M., & Weintraub, J. D. (1989). Assessing coping strategies: A theoretically based approach. Journal of Personality and Social Psychology, 56, 267–283.PubMedCrossRef

Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & Mcauliffe, T. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19(Suppl. 2), 124–133.PubMedCrossRef

Chesney, M., & Ickovics, J. (1997). For the recruitment, adherence and retention committee of the ACTG: Adherence to combination therapy in AIDS clinical trials. Presented at the annual meeting of the AIDS Clinical Trials Group, Washington.

Deeks, S., Beatty, G., Cohen, P. T., Grant, R., & Volberding, P. (1998). Viral load and CD+ T cell changes in patients failing potent protease inhibitor therapy [Abstract]. Fifth conference on Retroviruses and Opportunistic Infections, Chicago.

Gordillo, V., Del Amo, J., Soriano, V., & Gonzlez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13(Suppl. 13), 1763–1769.PubMedCrossRef

Goujard, C., Bernard, N., Sohier, N., Peyramond, D., Lancon, F., Chwalow, J., et al. (2003). Impact of a patient education program on adherence to HIV medication: A randomized clinical trial. Journal of Acquired Immune Deficiency Syndrome, 34(Suppl. 2), 191–194.CrossRef

Hill, Z., Kendall, C., & Fernandez, M. (2003). Patterns of adherence to antiretrovirals: Why adherence has no simple measure. AIDS Patient Care STDs, 17(Suppl. 10), 519–525.PubMedCrossRef

Hogg, R. S., Chan, K. J., Wood, E., Craib, K. J., O'Shaughnessy, M. V., & Montaner, J. S. (2001). Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. Journal of the American Medical Association, 286(20), 2597-2599.

Horne R., Weinman J., & Hankins, M. (1991). The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology and Health, 12, 1–24.

Ingledew, D. K., Hardy, L., Cooper, C. L., & Jemal, H. (1996). Health behaviours reported as coping strategies: A factor analytical study. British Journal of Health Psychology, 1, 263–281.

Kalichman, S. C., Rompa, D., Difonzo, K., Simpson, D., Austin, J., Luke, W., et al. (2001). HIV treatment adherence in women living with HIV/AIDS: Research based on the information–motivation–behavioral skills model of health behavior. Journal of the Association of Nurses in AIDS Care, 12(Suppl. 4), 58–67.PubMedCrossRef

Kievits, T., van Gemen, B., van Strijp, D., Schukkink, R., Dircks, M., & Adriaanse, H. (1991). NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. Journal of Virology Methods, 35(3), 273–286.CrossRef

LaPerriere, A., Ironson, G., Antoni, M., Jones, D., Devieux, J., Ishii, M., et al. (2005). CBSM+ group intervention decreases depression in moderately depressed women with AIDS: The SMART/EST Women’s Project. Journal of Health Psychology, 10, 223–231.PubMedCrossRef

Malcolm, S. E., Ng, J. J., Rosen, R. K., & Stone, V. E. (2003). An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care, 15(Suppl. 2), 251–261.PubMedCrossRef

McPherson-Baker, S., Malow, R., Penedo, F., Jones, D., Schneiderman, N., & Klimas, N. (2000). Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men. AIDS Care, 12, 399–404.PubMedCrossRef

Pakenham, K. I. (1998). Specification of social support behaviours and network dimensions along the HIV continuum for gay men. Patient Education, 34(2), 147–157.CrossRef

Paterson, D. L., Potoski, B., & Capitano, B. (2002). Measurement of adherence to antiretroviral medications. Journal of Acquired Immune Deficiency Syndrome, 31(Suppl. 3), S103–S106.

Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(Suppl. 1), 21–30.PubMed

Reiter, G. S., Stewart, K. E., & Wojtusik, L. (2000). Elements of success in HIV clinical care: Multiple interventions that promote adherence. Topics in HIV Medicine, 8(Suppl. 5), 21–30.

Remien, R. H., Hirky, A. E., Johnson, M. O., Weinhardt, L. S., Whittier, D., & Minh Le, G. (2003). Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four U.S. cities. AIDS and Behavior, 7(Suppl. 1), 61–72.CrossRef

Sankar, A., Luborsky, M., Schuman, P., & Roberts, G. (2002). Adherence discourse among African-American women taking HAART. AIDS Care, 14(Suppl. 2), 203–218.PubMedCrossRef

Segal-Isaacson, C. J., Tobin, J. N., Weiss, S. M., Brondolo, E., Vaughn, A., Wang, C., et al. (2006). Improving dietary habits in disadvantaged women with HIV/AIDS: The SMART/EST Women’s Project. AIDS and Behavior (in press).

Simoni, J. M., Frick, P. A., Lockhart, D., & Liebovitz, D. (2002). Mediators of social support and antiretroviral adherence among an indigent population in New York city. AIDS Patient Care and STDs, 16(Suppl. 9), 431–439.PubMedCrossRef

Spiegel, D., & Yalom, I. (1981). Group support for patients with metastatic breast cancer. Archives of General Psychiatry, 38, 527–533.PubMed

Stone, V. E., Hogan, J. W., Schuman, P., Rompalo, A. M., Howard, A. A., Korkontzelou, C., et al. (2001). Antiretroviral regimen complexity, self-reported adherence, and HIV patient’s understanding of their regimens: Survey of women in the HER study. Journal of Acquired Immune Deficiency Syndrome, 28(Suppl. 2), 124–131.

Wagner, G. J., Remien, R. H., Carballo-Dieguez, A., & Dolezal, C. (2002). Correlates of adherence to combination antiretroviral therapy among members of HIV-positive mixed status couples. AIDS Care, 14(Suppl. 1), 105–109.PubMedCrossRef

Titel: Efficacy of a Group Medication Adherence Intervention Among HIV Positive Women: The SMART/EST Women’s Project
verfasst von: Deborah L. Jones
Shvawn McPherson-Baker
David Lydston
Joanne Camille
Elizabeth Brondolo
Jonathan N. Tobin
Stephen M. Weiss
Publikationsdatum: 01.01.2007
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 1/2007
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-006-9165-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Efficacy of a Group Medication Adherence Intervention Among HIV Positive Women: The SMART/EST Women’s Project

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2007

Severe Anxiety Symptomatology and HIV Risk Behavior Among Hispanic Injection Drug Users in Puerto Rico

Differences in HIV Risk Behaviors by Gender in a Sample of Tanzanian Injection Drug Users

A Telephone-Based Intervention for Depression in HIV Patients: Negative Results from a Randomized Clinical Trial

Adherence to generic reverse transcriptase inhibitor-based antiretroviral medication at a Tertiary Center in North India

Sexual risk-taking and HIV testing among health workers in Zambia

Editorial: The Impact of AIDS and Behavior

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin